| Product NDC: | 50458-255 |
| Proprietary Name: | Haldol |
| Non Proprietary Name: | Haloperidol |
| Active Ingredient(s): | 5 mg/mL & nbsp; Haloperidol |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50458-255 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA015923 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19710518 |
| Package NDC: | 50458-255-01 |
| Package Description: | 10 AMPULE in 1 BOX (50458-255-01) > 1 mL in 1 AMPULE |
| NDC Code | 50458-255-01 |
| Proprietary Name | Haldol |
| Package Description | 10 AMPULE in 1 BOX (50458-255-01) > 1 mL in 1 AMPULE |
| Product NDC | 50458-255 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Haloperidol |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19710518 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | HALOPERIDOL |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |